Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Mucosal Immunity

This article is part of the Research TopicHost-Pathogen Interactions in Mucosal ImmunologyView all 6 articles

Effectiveness of Streptococcus salivarius probiotics on Alleviating Radiation-Induced Oral Mucositis via Inflammatory and Microecological Modulation: A Prospective Pragmatic Interventional Study in Nasopharyngeal Carcinoma

Provisionally accepted
Xiaotong  HuangXiaotong Huang1,2*Hui  FengHui Feng1Ye  TanYe Tan1Quan  WangQuan Wang3Jie-Mei  WeiJie-Mei Wei4Zhao-Dong  HuangZhao-Dong Huang4Haijun  LuHaijun Lu1*Xin-Tong  WangXin-Tong Wang1*
  • 1The Affiliated Hospital of Qingdao University, Qingdao, China
  • 2Qingdao University, Qingdao, China
  • 3Qingdao Central Hospital of University of Health and Rehabilitation Sciences, Qingdao, China
  • 4Linyi Central Hospital, Linyi, China

The final, formatted version of the article will be published soon.

Background: Radiation-induced oral mucositis (OM) is a prevalent and debilitating complication of head and neck radiotherapy, yet its severity varies markedly between patients. Emerging evidence suggests that this heterogeneity is influenced by the pre-existing oral microbiome and host inflammatory tone. Methods: This prospective, pragmatic interventional study grouped nasopharyngeal carcinoma (NPC) patients receiving chemoradiotherapy by probiotic exposure: no probiotic, Streptococcus salivarius K12 (SsK12), or Streptococcus salivarius M18 (SsM18). Weekly oral assessments were used to characterize the onset, duration, and severity of OM. Group-based trajectory modeling (GBTM) was used to identify OM trajectories. Univariate, multivariate, and mediation analyses were used to explore associated factors and potential relationships. Results: Among 69 evaluable patients, OM occurred in 95.7%, with severe OM (SOM) in 42.4%. Compared with non-probiotic group, SsM18 significantly delayed OM onset (p = 0.014), reduced SOM duration (p = 0.019), and shortened total OM duration (p = 0.031), outperforming SsK12. GBTM identified two distinct OM trajectories: 'Rapid-Onset, Severe' group and 'Late-Onset, Mild' group. Multivariate analysis revealed that elevated log-transformed Interleukin-6 levels (odds ratio [OR] = 4.20, p = 0.020), and high Beck Oral Assessment Scale (BOAS) score (OR=3.06, p = 0.044) as independent predictors of 'Rapid-Onset, Severe' trajectory. The Teeth subdomain of BOAS was identified as an independent predictor for earlier OM onset (p = 0.042). Mediation analysis suggested that the association between a higher Teeth subdomain score and OM was partially mediated by IL-6 elevation (proportion mediated: 30–50%). Conclusions: Radiotherapy-induced OM was associated with baseline oral health and inflammatory status. SsM18 supplementation was associated with improved OM-related outcomes, suggesting a potential role for precision probiotic strategies.

Keywords: ecological inflammation, IL-6, IL-8, oral microbiome, Probiotics, Radiation-Induced Oral Mucositis, Streptococcus salivarius K12, Streptococcus salivarius M18

Received: 13 Nov 2025; Accepted: 13 Feb 2026.

Copyright: © 2026 Huang, Feng, Tan, Wang, Wei, Huang, Lu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xiaotong Huang
Haijun Lu
Xin-Tong Wang

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.